US20210024936A1
University of Texas System
Provided herein are compositions of lipid-based nanoparticles, such as exosomes, that comprise a therapeutic agent that inhibits the activity of an oncogene. Also provided are methods of using such compositions to treat a patient having a cancer caused by the activation of the oncogene. In …